TerminatedPhase 3NCT00072215
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alliance for Clinical Trials in Oncology
- Principal Investigator
- Robert J. Motzer, MDMemorial Sloan Kettering Cancer Center
- Intervention
- cisplatin(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 18-120 years · MALE
- Timeline
- 2004 – 2005
Study locations (30)
- Northeast Alabama Regional Medical Center, Anniston, Alabama, United States
- Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
- Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States
- Naval Medical Center - San Diego, San Diego, California, United States
- Veterans Affairs Medical Center - San Diego, San Diego, California, United States
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States
- CCOP - Christiana Care Health Services, Newark, Delaware, United States
- Lombardi Cancer Center at Georgetown University Medical Center, Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center, Washington D.C., District of Columbia, United States
- Veterans Affairs Medical Center - Washington, DC, Washington D.C., District of Columbia, United States
- Broward General Medical Center, Fort Lauderdale, Florida, United States
- Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, United States
- CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States
- Florida Hospital Cancer Institute, Orlando, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00072215 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology